Search by Drug Name or NDC

    NDC 58602-0721-57 Athentia Next 1.5 mg/1 Details

    Athentia Next 1.5 mg/1

    Athentia Next is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Aurohealth LLC. The primary component is LEVONORGESTREL.

    Product Information

    NDC 58602-0721
    Product ID 58602-721_d65db291-ef1d-4893-a22a-f29315fc2eb5
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Athentia Next
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levonorgestrel
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 1.5
    Active Ingredient Units mg/1
    Substance Name LEVONORGESTREL
    Labeler Name Aurohealth LLC
    Pharmaceutical Class Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206867
    Listing Certified Through 2024-12-31

    Package

    NDC 58602-0721-57 (58602072157)

    NDC Package Code 58602-721-57
    Billing NDC 58602072157
    Package 1 BLISTER PACK in 1 CARTON (58602-721-57) / 1 TABLET in 1 BLISTER PACK
    Marketing Start Date 2015-12-08
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 34e5aa53-3943-4e2f-93aa-b5a4d779a703 Details

    Revised: 11/2022